← Leaderboards
John D Clements
Tulane University Of Louisiana
$19,870,217
Attributed
$19,870,217
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $13.5M · FY2005–15$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$19,870,217 · 7
By mechanism
C06$13,533,254 · 1
R01$2,379,659 · 2
U01$2,297,246 · 1
R21$1,094,554 · 2
R56$565,504 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Elizabeth B Norton$7,814,261
- Karol Sestak$5,154,708
- Elizabeth Norton$11,287,780
- Lu Qi$19,868,722
- Louise Braud Lawson$560,775
Others in their field
Top investigators on “Yersinia Pestis”
- Samuel L. Stanley · Washington University$14,179,569
- Olaf Schneewind · University Of California Los Angeles$12,579,623
- David Alland · Rutgers Biomedical And Health Sciences$12,462,803
- Carolyn Hovde Bohach · University Of Idaho$10,335,728
- Kelly J. Henrickson · Medical College Of Wisconsin$9,863,102
- Bradford Seamon · Booz Allen Hamilton, Inc.$9,711,242
Research focus
Yersinia PestisImmunityImmunizationLaboratory MouseCessation Of LifeAnimalsProteinsChildLifeVaccinesBioterrorism /Chemical WarfareCommunicable DiseasesVaccine DeliveryAntigensPreventBacillus AnthracisMorbidity - Disease RateMortality Vital StatisticsCellsMucosal ImmunityTherapeutic VaccineImmunomodulatorsImmunologicsInfection
Grant awards (18)
Physiologic and immunologic consequences of exposure to ETEC enterotoxins$188,125
R21 · FY2015 · AI · contact PI
Physiologic and immunologic consequences of exposure to ETEC enterotoxins$225,750
R21 · FY2014 · AI · contact PI
Nanocarriers for Vaccine Delivery$565,504
R56 · FY2013 · AI · contact PI
Tulane_University_Interdisciplinary_Bioscience_Initiative$13,533,254
C06 · FY2010 · RR · contact PI
Nanocarriers for transcutaneous delivery of vaccines$500,712
R01 · FY2009 · EB · contact PI
Nanocarriers for transcutaneous delivery of vaccines$486,465
R01 · FY2008 · EB · contact PI
Nanocarriers for transcutaneous delivery of vaccines$492,665
R01 · FY2007 · EB · contact PI
Novel adjuvants for biodefense vaccines$267,814
U01 · FY2007 · AI · contact PI
Nanocarriers for transcutaneous delivery of vaccines$502,990
R01 · FY2006 · EB · contact PI
Novel adjuvants for biodefense vaccines$270,029
U01 · FY2006 · AI · contact PI
Combinatorial vaccines against anthrax and plague$70,179
R21 · FY2006 · AI · contact PI
Novel adjuvants for biodefense vaccines$270,779
U01 · FY2005 · AI
Novel adjuvants for biodefense vaccines$460,814
U01 · FY2004 · AI
Combinatorial vaccines against anthrax and plague$313,500
R21 · FY2004 · AI
Novel adjuvants for biodefense vaccines$1,027,810
U01 · FY2003 · AI
Combinatorial vaccines against anthrax and plague$297,000
R21 · FY2003 · AI
MECHANISM OF CHOLERA TOXIN AND E COLI LT ADJUVANTICITY$201,345
R01 · FY2001 · AI
MECHANISM OF CHOLERA TOXIN AND E COLI LT ADJUVANTICITY$195,482
R01 · FY2000 · AI